Posted By Wanda Rich
Posted on September 27, 2021
According to a new report published by Allied Market Research, titled,“Immunoglobulin Market by Application, Mode of Delivery, Products Type and Geography: Global Opportunity Analysis and Industry Forecast, 2018 – 2025,”the immunoglobulin market accounted for $9,972.9 million in 2017, and is projected to reach $16,694.7 million by 2025, registering a CAGR of 6.6% from 2018 to 2025.
Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2586
Based on application segment, hypogammaglobulinemia was the largest revenue contributor in 2017 towards market growth and is anticipated to continue this trend in the near future. Large patient population, lack of effective substitute treatment, and early adoption of immunoglobulin for the treatment of hypogammaglobulinemia are expected to boost the growth of this segment.
Key Findings of the Immunoglobulin Market:
- Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
- Hypogammaglobulinemia was the highest revenue-generating segment in 2017 and is expected to continue its dominance during the forecast period.
- North America dominated global immunoglobulins market and is projected to grow at a CAGR of 6.3%.
- Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 8.0%.
- LAMEA segment was the fastest growing segment growing at a CAGR of 9.4%.
In 2017, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.
Get Detailed COVID-19 Impact Analysis on the Immunoglobulin Market @ https://www.alliedmarketresearch.com/request-for-customization/2586?reqfor=covid
The key companies profiled in the report include Baxter international Inc., CSL Ltd, Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products Inc., Shire (Baxalta), and Bayer Healthcare.
Interested to Procure the Data? Inquire here @ https://www.alliedmarketresearch.com/purchase-enquiry/2586
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
According to a new report published by Allied Market Research, titled,“Immunoglobulin Market by Application, Mode of Delivery, Products Type and Geography: Global Opportunity Analysis and Industry Forecast, 2018 – 2025,”the immunoglobulin market accounted for $9,972.9 million in 2017, and is projected to reach $16,694.7 million by 2025, registering a CAGR of 6.6% from 2018 to 2025.
Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2586
Based on application segment, hypogammaglobulinemia was the largest revenue contributor in 2017 towards market growth and is anticipated to continue this trend in the near future. Large patient population, lack of effective substitute treatment, and early adoption of immunoglobulin for the treatment of hypogammaglobulinemia are expected to boost the growth of this segment.
Key Findings of the Immunoglobulin Market:
- Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
- Hypogammaglobulinemia was the highest revenue-generating segment in 2017 and is expected to continue its dominance during the forecast period.
- North America dominated global immunoglobulins market and is projected to grow at a CAGR of 6.3%.
- Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 8.0%.
- LAMEA segment was the fastest growing segment growing at a CAGR of 9.4%.
In 2017, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.
Get Detailed COVID-19 Impact Analysis on the Immunoglobulin Market @ https://www.alliedmarketresearch.com/request-for-customization/2586?reqfor=covid
The key companies profiled in the report include Baxter international Inc., CSL Ltd, Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products Inc., Shire (Baxalta), and Bayer Healthcare.
Interested to Procure the Data? Inquire here @ https://www.alliedmarketresearch.com/purchase-enquiry/2586
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
